Back
Full-text
Journal article

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.

  • Weller M Department of Neurology, Brain Tumour Centre, University Hospital and University of Zurich, Zurich, Switzerland. Electronic address: michael.weller@usz.ch.
  • van den Bent M Neurooncology Unit, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Tonn JC Department of Neurosurgery, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Stupp R Department of Oncology, Brain Tumour Centre, University Hospital and University of Zurich, Zurich, Switzerland.
  • Preusser M Department of Medicine, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna, Austria.
  • Cohen-Jonathan-Moyal E Département de Radiotherapie, Institut Claudius Regaud, L'Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Henriksson R Regional Cancer Centre Stockholm-Gotland and Department of Radiation Sciences and Oncology, Umeå University Hospital, Umeå, Sweden.
  • Le Rhun E Neuro-Oncology, Department of Neurosurgery, University Hospital, Lille, France.
  • Balana C Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Barcelona, Spain.
  • Chinot O Department of Neuro-Oncology, Aix-Marseille Université, Assistance Publique-Hopitaux de Marseille, Centre Hospitalo-Universitaire Timone, Marseilles, France.
  • Bendszus M Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
  • Reijneveld JC Department of Neurology and Brain Tumour Centre Amsterdam, Vrije Universiteit Medical Centre, Amsterdam, Netherlands.
  • Dhermain F Department of Radiotherapy, Gustave Roussy University Hospital, Villejuif, France.
  • French P Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Marosi C Department of Medicine, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna, Austria.
  • Watts C Department of Clinical Neurosciences, Division of Neurosurgery, University of Cambridge, Cambridge, UK.
  • Oberg I Division of Neurosurgery, Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust, Cambridge, UK.
  • Pilkington G Brain Tumour Research Centre, University of Portsmouth, Portsmouth, UK.
  • Baumert BG Department of Radiation Oncology, MediClin Robert Janker Clinic and Clinical Cooperation Unit Neurooncology, University of Bonn Medical Centre, Bonn, Germany.
  • Taphoorn MJB Department of Neurology, Leiden University Medical Centre and Medical Centre Haaglanden, The Hague, Netherlands.
  • Hegi M Department of Clinical Neurosciences, University Hospital Lausanne, Lausanne, Switzerland.
  • Westphal M Department of Neurosurgery, University Hospital Hamburg, Hamburg, Germany.
  • Reifenberger G Department of Neuropathology, Heinrich Heine University Düsseldorf and German Cancer Consortium (DKTK), Essen/Düsseldorf, Germany.
  • Soffietti R Department of Neuro-Oncology, University Hospital, Turin, Italy.
  • Wick W Neurology Clinic and National Centre for Tumour Diseases, University Hospital Heidelberg, Heidelberg, Germany; German Consortium of Translational Cancer Research (DKTK), Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
Show more…
  • 2017-05-10
Published in:
  • The Lancet. Oncology. - 2017
Adult
Antineoplastic Agents
Astrocytoma
Brain Neoplasms
Combined Modality Therapy
Humans
Magnetic Resonance Imaging
Molecular Diagnostic Techniques
Neuroimaging
Oligodendroglioma
Positron-Emission Tomography
Radiotherapy
English The European Association for Neuro-Oncology guideline provides recommendations for the clinical care of adult patients with astrocytic and oligodendroglial gliomas, including glioblastomas. The guideline is based on the 2016 WHO classification of tumours of the central nervous system and on scientific developments since the 2014 guideline. The recommendations focus on pathological and radiological diagnostics, and the main treatment modalities of surgery, radiotherapy, and pharmacotherapy. In this guideline we have also integrated the results from contemporary clinical trials that have changed clinical practice. The guideline aims to provide guidance for diagnostic and management decisions, while limiting unnecessary treatments and costs. The recommendations are a resource for professionals involved in the management of patients with glioma, for patients and caregivers, and for health-care providers in Europe. The implementation of this guideline requires multidisciplinary structures of care, and defined processes of diagnosis and treatment.
Language
  • English
Open access status
green
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/21810
Statistics
Document views: 8 File downloads:
  • fulltext.pdf: 0